Market capitalisation
?
Share price multiplied by shares outstanding. It does not measure company cash.
Company analysis·GUD.TO
Preparing the analysis
We’re preparing the company’s analysis.
TSX·GUD.TO
Knight Therapeutics Inc.
Share priceCA$11.47Price as of: Nov 9, 2026
Knight Therapeutics Inc. (GUD.TO) is a company listed on TSX, classified under Drug Manufacturers - Specialty & Generic.
Knight Therapeutics Inc., a specialty pharmaceutical enterprise established in Montreal, Canada in 2013, operates globally, with a strong presence across Canada and Latin America.
Revenue · FY 2025
?
Sales generated during the period, before costs and expenses.
Net margin · FY 2025
?
Net income as a proportion of revenue.
“Our take” and other explanations are generated with artificial intelligence from the data, without human review of each text. They are descriptive, not recommendations. Learn more
Explore questions
P1 · What does it do and how does it make money?
How this companymakes money.
$450mrevenue in FY 2025
—breakdown not available from our provider
0business lines with data
After that close
Q3 2026, ended Sep 30, 2026: total revenue +13.3% against the same quarter a year earlier.
This is the revenue of the whole company. The split by lines and regions on this page is still that of the full fiscal year.01How it makes money
Revenue breakdown not available
Our data provider does not have a revenue breakdown by business line for this company. This does not necessarily mean that the company does not publish this information.
03Where sales come from
Geographic breakdown not available
Our data provider does not have a breakdown of revenue by country or region for this company. This does not necessarily mean that the company does not publish this information.
Calculated reading
Our source does not publish Knight Therapeutics Inc.’s revenue by business line, so we cannot measure how much it depends on each activity.
These are this section’s calculations, without the written analysis yet. It is not investment advice.
Next step